Fox, Maria Laura http://orcid.org/0000-0002-0062-6607
García-Cadenas, Irene http://orcid.org/0000-0002-2994-9055
Navarro, Victor
Martínez, Ariadna Pérez
Kara, Meriem
Bazán, Irene Sánchez
Ferra Coll, Christelle
Bailén, Rebeca http://orcid.org/0000-0003-2838-1776
Bento, Leyre http://orcid.org/0000-0001-9929-8617
Parody, Rocío
Esquirol, Albert http://orcid.org/0000-0002-6062-5980
Ortí, Guillermo
Mussetti, Alberto
Salamero, Olga
Martino, Rodrigo http://orcid.org/0000-0001-5143-4042
González, Ana Pérez
Barba, Pere
Kwon, Mi
Solano, Carlos http://orcid.org/0000-0003-3702-0817
Bosch, Francesc
Valcárcel, David http://orcid.org/0000-0002-8747-078X
,
Article History
Received: 22 February 2024
Revised: 21 May 2024
Accepted: 24 May 2024
First Online: 24 June 2024
Competing interests
: R.B.A.: Speaker: Pfizer, Gilead. Travel: Jazz, Pfizer, Gilead, AstraZeneca. Funding: Jazz. M.K. Gilead, Novartis, BMS and Pfizer. All other authors declare no competing financial interests. The current affiliation for CF is Division of Hematology, Hospital del Mar, Barcelona, Spain.
: All transplantation centers are required to obtain written informed consent from all patients before data registration with the EBMT in accordance with the 1975 Helsinki Declaration.
: Institutional Review and Privacy Board of University Hospital Vall d´Hebron granted approval for this retrospective review (reference code HEM-TIO-2017-01).